<DOC>
	<DOCNO>NCT02686398</DOCNO>
	<brief_summary>During 2013-2014 influenza season , CKD patient undergo HD participate study . The patient randomize two group ( MF59-adjuvanted vaccine group non-adjuvanted vaccine group ) immunize respective vaccine . Sera collect prior vaccination 1and 6 month post vaccination . Levels hemagglutination inhibition ( HI ) antibody measure .</brief_summary>
	<brief_title>Immunogenicity Trivalent Influenza Vaccine Chronic Kidney Disease Patients Undergoing Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Chronic kidney disease patient undergoing hemodialysis Who give write informed consent time enrollment Recipients influenza vaccine 20132014 season study History egg allergy</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Influenza Vaccines</keyword>
	<keyword>MF59 oil emulsion</keyword>
	<keyword>End Stage Renal Failure Dialysis</keyword>
</DOC>